Xenetic Biosciences Analyst Price Targets - Benzinga

Xenetic Biosciences Inc

XBIONASDAQ

Trade with Public

Trade with Public

$1.99

-0.02-1%

最終更新: Oct 15, 9:11 AM

$2.10

0.094.48%

概要ニュース業績予想イベント目標株価財務センチメント比較株式レポート

Xenetic Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xenetic Biosciences (XBIO).

Analyst Consensus — 1 Analysts

1Hold

# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 9, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Mar 20, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Dec 5, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Nov 22, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Aug 20, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciences

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) with a Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciences

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) with a Neutral.

Benzinga Newsdesk

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences

Vandana Singh